Press Releases
March 9, 2021
Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF Pharmaceuticals
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021March 5, 2021
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
TFF Pharmaceuticals Provides Update on Clinical Development ProgramsMarch 4, 2021
TFF Pharmaceuticals Provides Update on Clinical Development Programs
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021February 24, 2021
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)February 19, 2021
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital ConferenceFebruary 12, 2021
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference
TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 ConferenceJanuary 7, 2021
TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical TrialDecember 15, 2020
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical Trial
TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare ConferenceNovember 12, 2020
TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business ResultsNovember 5, 2020
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results